Inspire Medical Systems, Inc.
Inspire Medical Systems Announces $200M Share Repurchase Program
Summary
Inspire Medical Systems, Inc. announced that its Board of Directors has authorized the repurchase of up to $200 million of the Company's outstanding shares of common stock. The repurchase program is intended to return capital to stockholders and represents the company's confidence in its growth prospects and stock value. The program allows for flexibility in timing, manner, price, and amount of repurchases, and it will expire on August 7, 2027, or earlier at the discretion of the Board.
Profitelligence Alerts
Get alerts for INSP
Be first to know when Inspire Medical Systems, Inc. files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a pioneering company focused on developing and commercializing innovative medical technology designed to treat obstructive sleep apnea (OSA). The company's flagship product, the Inspire therapy, is an implantable neurostimulation device that provides a unique and effective solution for patients who are unable to utilize traditional continuous positive airway pressure (CPAP) devices. Inspire Medical Systems significantly impacts the healthcare sector by offering a less invasive, patient-friendly alternative to surgical treatments for OSA, improving quality of life for those affected by sleep disorders. Headquartered in Minnesota, Inspire Medical Systems continues to expand its presence within the medical device market, collaborating closely with hospitals and medical professionals to enhance sleep health management globally. This company's contributions underscore a growing focus on personalized and technologically advanced approaches to medical challenges, marking its importance in the evolving landscape of healthcare solutions.
Official SEC Documents
Advertisement